H Grant Skaggs Jr

Array ( [id] => 6447230 [patent_doc_number] => 20100105069 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-29 [patent_title] => 'METHOD FOR DETECTING HUMAN PARVOVIRUS ANTIGEN' [patent_app_type] => utility [patent_app_number] => 12/519063 [patent_app_country] => US [patent_app_date] => 2006-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 4391 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20100105069.pdf [firstpage_image] =>[orig_patent_app_number] => 12519063 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8896894 [patent_doc_number] => 08476416 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-02 [patent_title] => 'Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes' [patent_app_type] => utility [patent_app_number] => 11/637184 [patent_app_country] => US [patent_app_date] => 2006-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 53 [patent_figures_cnt] => 56 [patent_no_of_words] => 8998 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 136 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11637184 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5188427 [patent_doc_number] => 20070166735 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-19 [patent_title] => 'METHODS OF IN VITRO PROPAGATION AND DETECTION OF INFECTIOUS PRION' [patent_app_type] => utility [patent_app_number] => 11/566094 [patent_app_country] => US [patent_app_date] => 2006-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 6694 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20070166735.pdf [firstpage_image] =>[orig_patent_app_number] => 11566094 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8184209 [patent_doc_number] => 20120114683 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-10 [patent_title] => 'Nucleic Acid Encoding TGEV and PRRSV Sequences for Improved Expression of PRRSV Sequences' [patent_app_type] => utility [patent_app_number] => 12/085924 [patent_app_country] => US [patent_app_date] => 2006-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 21455 [patent_no_of_claims] => 67 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0114/20120114683.pdf [firstpage_image] =>[orig_patent_app_number] => 12085924 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5479631 [patent_doc_number] => 20090202588 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-13 [patent_title] => 'Nucleic acids encoding TGEV and PRRSV sequences for improved expression of PRRSV sequences' [patent_app_type] => utility [patent_app_number] => 11/606237 [patent_app_country] => US [patent_app_date] => 2006-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 21469 [patent_no_of_claims] => 67 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20090202588.pdf [firstpage_image] =>[orig_patent_app_number] => 11606237 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6320904 [patent_doc_number] => 20100196451 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-05 [patent_title] => 'Vaccines Containing Non-Live Antigenic Vectors' [patent_app_type] => utility [patent_app_number] => 12/095539 [patent_app_country] => US [patent_app_date] => 2006-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 11647 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0196/20100196451.pdf [firstpage_image] =>[orig_patent_app_number] => 12095539 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5095526 [patent_doc_number] => 20070117135 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-24 [patent_title] => 'Method of inoculation for evaluating candidate therapies for prevention of acquisition of infectious diseases' [patent_app_type] => utility [patent_app_number] => 11/604015 [patent_app_country] => US [patent_app_date] => 2006-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 1021 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20070117135.pdf [firstpage_image] =>[orig_patent_app_number] => 11604015 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4886865 [patent_doc_number] => 20080261197 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-23 [patent_title] => 'Nucleotide sequences of HIV-1 group (or subgroup) O retroviral antigens' [patent_app_type] => utility [patent_app_number] => 11/591678 [patent_app_country] => US [patent_app_date] => 2006-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 15312 [patent_no_of_claims] => 93 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0261/20080261197.pdf [firstpage_image] =>[orig_patent_app_number] => 11591678 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5100796 [patent_doc_number] => 20070184058 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-09 [patent_title] => 'Glucocerebroside treatment of pulmonary or respiratory diseases or disorders' [patent_app_type] => utility [patent_app_number] => 11/591153 [patent_app_country] => US [patent_app_date] => 2006-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4448 [patent_no_of_claims] => 109 [patent_no_of_ind_claims] => 84 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0184/20070184058.pdf [firstpage_image] =>[orig_patent_app_number] => 11591153 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8908992 [patent_doc_number] => 08481051 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-09 [patent_title] => 'Cytotoxic T-cell epitope peptides that specifically attack epstein-barr virus-infected cells and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/091705 [patent_app_country] => US [patent_app_date] => 2006-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 20021 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12091705 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6137487 [patent_doc_number] => 20110009604 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-13 [patent_title] => 'Method for Concentrating, Purifying and Removing Prion Protein' [patent_app_type] => utility [patent_app_number] => 12/083971 [patent_app_country] => US [patent_app_date] => 2006-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10586 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20110009604.pdf [firstpage_image] =>[orig_patent_app_number] => 12083971 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5062953 [patent_doc_number] => 20070224593 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-27 [patent_title] => 'Diagnosis of transmissible spongiform encephalopathy' [patent_app_type] => utility [patent_app_number] => 11/583319 [patent_app_country] => US [patent_app_date] => 2006-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7571 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20070224593.pdf [firstpage_image] =>[orig_patent_app_number] => 11583319 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6576464 [patent_doc_number] => 20100047231 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-25 [patent_title] => 'Immuno-Stimulant Combination for Prophylaxis and Treatment of Hepatitis C' [patent_app_type] => utility [patent_app_number] => 12/083217 [patent_app_country] => US [patent_app_date] => 2006-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6675 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0047/20100047231.pdf [firstpage_image] =>[orig_patent_app_number] => 12083217 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6636142 [patent_doc_number] => 20100226938 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-09 [patent_title] => 'Cellular and viral inactivation' [patent_app_type] => utility [patent_app_number] => 11/525250 [patent_app_country] => US [patent_app_date] => 2006-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13592 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20100226938.pdf [firstpage_image] =>[orig_patent_app_number] => 11525250 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6280455 [patent_doc_number] => 20100119524 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-13 [patent_title] => 'ADJUVANTED VACCINE' [patent_app_type] => utility [patent_app_number] => 12/067535 [patent_app_country] => US [patent_app_date] => 2006-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 13342 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20100119524.pdf [firstpage_image] =>[orig_patent_app_number] => 12067535 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5502255 [patent_doc_number] => 20090162943 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-25 [patent_title] => 'Reagents and Methods for the Detection of Transmissible Spongiform Encephalopathy' [patent_app_type] => utility [patent_app_number] => 11/992160 [patent_app_country] => US [patent_app_date] => 2006-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 9696 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20090162943.pdf [firstpage_image] =>[orig_patent_app_number] => 11992160 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5079575 [patent_doc_number] => 20070122799 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-31 [patent_title] => 'Method of isolation and self-assembly of small protein particles from blood and other biological materials' [patent_app_type] => utility [patent_app_number] => 11/523250 [patent_app_country] => US [patent_app_date] => 2006-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 22927 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20070122799.pdf [firstpage_image] =>[orig_patent_app_number] => 11523250 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 859835 [patent_doc_number] => 07371386 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-05-13 [patent_title] => 'Conserved motif of hepatitis C virus E2/NS1 region' [patent_app_type] => utility [patent_app_number] => 11/522614 [patent_app_country] => US [patent_app_date] => 2006-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 11 [patent_no_of_words] => 13803 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/371/07371386.pdf [firstpage_image] =>[orig_patent_app_number] => 11522614 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5265785 [patent_doc_number] => 20090118470 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-07 [patent_title] => 'Prion Inactivation' [patent_app_type] => utility [patent_app_number] => 12/064682 [patent_app_country] => US [patent_app_date] => 2006-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5527 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20090118470.pdf [firstpage_image] =>[orig_patent_app_number] => 12064682 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 228693 [patent_doc_number] => 07601506 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-10-13 [patent_title] => 'Identification of leucocytes bearing diagnostic markers for transmissible spongiform encephalopathies' [patent_app_type] => utility [patent_app_number] => 11/494964 [patent_app_country] => US [patent_app_date] => 2006-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7040 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/601/07601506.pdf [firstpage_image] =>[orig_patent_app_number] => 11494964 [rel_patent_id] =>[rel_patent_doc_number] =>)